SCOTTSDALE, AZ — Arizona is set to become a global leader in psilocybin research.
Scottsdale Research Institute announced on May 28 that it will lead the first government-funded study measuring the effects of natural psilocybin mushrooms when treating individuals with life-threatening illnesses. The initiative will proceed after SRI, led by President Sue Sisley, MD, was awarded roughly $2.75 million of a $5 million grant that Arizona leaders had previously dedicated to natural psilocybin research.
Do you have a concern in your community or a news tip? We want to hear from you!
Connect with us: share@abc15.com
Military veterans, firefighters, and Arizonans with terminal illnesses successfully advocated for the Legislature to approve the grant.
Arizona is now the first state in the United States with a legal DEA-approved clinical treatment study using natural, self-grown psilocybin mushrooms — sometimes referred to as "magic mushrooms" for their psychedelic qualities. SRI's research could have widespread ramifications on individuals suffering from chronic pain, post-traumatic stress disorder, and other physical and mental illnesses.
